Evidence map›Paper›PMID 38355842›Full record

ArticleAAPS PharmSciTech2024

The Use of Data Mining for Obtaining Deeper Insights into the Fabrication of Prednisolone-Loaded Chitosan Nanoparticles.

Jehad Nasereddin, Reem Al Wadi, Ahlam Zaid Al-Kilani, Asad Abu Khalil, Mohammad Al Natour, Wael Abu Dayyih

Abstract read
PubMed Publisher
In one paragraph

Article in AAPS PharmSciTech, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jehad NasereddinDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Zarqa University, Zarqa, 13110, Jordan. jnasereddin@zu.edu.jo.ORCID http://orcid.org/0000-0003-3095-211X
Reem Al WadiDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Zarqa University, Zarqa, 13110, Jordan.
Ahlam Zaid Al-KilaniDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Zarqa University, Zarqa, 13110, Jordan.
Asad Abu KhalilDepartment of Pharmaceutics and Pharmaceutical Technology, The Faculty of Pharmacy and Medical Sciences, University of Petra, Amman, 11196, Jordan.
Mohammad Al NatourDepartment of Pharmaceutics and Pharmaceutical Technology, The Faculty of Pharmacy and Medical Sciences, University of Petra, Amman, 11196, Jordan.
Wael Abu DayyihFaculty of Pharmacy, Mutah University, Al Karak, 61710, Jordan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present work explores a data mining approach to study the fabrication of prednisolone-loaded chitosan nanoparticles and their properties. Eight PLC formulations were prepared using an automated adaptation of the antisolvent precipitation method. The PLCs were characterized using dynamic light scattering, infrared spectroscopy, and drug release studies. Results showed that that the effective diameter, loading capacity, encapsulation efficiency, zeta potential, and polydispersity of the PLCs were influenced by the concentration and molecular weight of chitosan. The drug release studies showed that PLCs exhibited significant dissolution enhancement compared to pure prednisolone crystals. Principal components analysis and partial least squares regression were applied to the infrared spectra and the DLS data to extract higher-order interactions and correlations between the critical quality attributes and the diameter of the PLCs. Principal components revealed that the spectra clustered according to the type of material, with PLCs forming a separate cluster from the raw materials and the physical mix. PLS was successful in predicting the ED of the PLCs from the FTIR spectra with R

Indexed as

ChitosanNanoparticlesDrug CarriersDrug LiberationParticle SizePrednisoloneSpectroscopy, Fourier Transform InfraredChitosanDrug CarriersPrednisolonechemometricsdata miningnanoparticlesPLS regressionspectroscopy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.